Antibody cocktails could steer viruses into evolutionary dead ends
When a virus mutates, the world usually finds out the hard way. Variants of influenza and SARS-CoV-2 can slip past vaccines and antibody drugs before scientists fully understand what has changed. A new study from Harvard's Department of Chemistry and Chemical Biology (CCB) suggests the hard way may...
Image: Phys.org
When a virus mutates, the world usually finds out the hard way. Variants of influenza and SARS-CoV-2 can slip past vaccines and antibody drugs before scientists fully understand what has changed. A new study from Harvard's Department of Chemistry and Chemical Biology (CCB) suggests the hard way may not be inevitable.
Originally published at Phys.org
